An international team of researchers has called for the development of a vaccine against the Coronavirus, studies with voluntary and infected subjects to prepare.

“In view of the special circumstances of the pandemic, our model Framework and our analysis, a basis for Sars-CoV 2-support to set Challenges,” writes the Team led by first author Seema Shah of Northwestern University in Chicago, in the journal ‘Science’.

Risks to study participants, to minimize

The authors stress that risks need to be minimized for study participants, personnel and third parties. For instance, young, healthy people should be selected as subjects and their state of health in the long term, observed.

Clinical studies with volunteer Infected could have been in the Corona-crisis “in multiple ways with a high social value,” the scientists write.

Human Challenge Trials are controversial

Called a Human Challenge Trials so the English term is for this type of study are debated among scientists. Proponents argue that you can speed up the development of medical agents.

Others point to high health risks and ethical concerns. In Germany, there has not been a “Human Challenge Trials” in this Form.

Source

• Seema K. Shah, et. al. (2020): the Ethics of controlled human infection to study COVID-19, retrieved on 08.05.2020 https://science.sciencemag.org/content/early/2020/05/06/science.abc1076

Deutsche Presse-Agentur (dpa)

*The post “vaccines against the Coronavirus: a researcher for Corona studies with volunteer Infected” will be released by FitForFun. Contact with the executives here.